[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_409",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_409"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB00744"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"The use of Zileuton Extended-Release Tablets is contraindicated in patients with:   Active liver disease or persistent hepatic function enzyme elevations greater than or equal to 3 times the upper limit of normal (>=3xULN) [see    Warnings and Precautions (5)   Use in Specific Populations (8.7) A history of allergic reaction to zileuton or any of the ingredients of Zileuton Extended Release Tablets (e.g., rash, eosinophilia, etc.).   Active liver disease or persistent hepatic function enzyme elevations >=3 times the upper limit of normal. ( 4 5.1 History of allergic reaction to Zileuton or any of the ingredients of Zileuton Extended-Release Tablets. ( 4\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB00744",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-25T13:58:13.360+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "X7+BvuEhn6t7Pam8pE9RWoXjVgYaYfbQ9BDFItywvs/blGatCdU5TMO9gR4W+6o73frnCoSPDSj4KmrVnMjtAOaEmK8lPjPe3BHj1eaTtQmvOxVJZ6QT++lEmuM4lqdfw/93RRcLHFIszw7g/1uIcG5xWupEHoJceKRDpFv7dzg="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI"
    } ]
  } ],
  "@id" : "http://purl.org/np/RASrQxw3symNpsQWZ1tQhjE12x7WiOB4ymboKpwqt9KrI#pubinfo"
} ]